SCHEMBL29435604

SCHEMBL29435604

Cc1cccnc1-c1nc(Br)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 2/20 0.41
▸ PDE10A Q9Y233 1/20 0.39
▸ METAP2 P50579 1/20 0.38
▸ NOS3 P29474 1/20 0.36
▸ NOS1 P29475 1/20 0.36
▸ NOS2 P35228 1/20 0.36
▸ CYP19A1 P11511 2/20 0.35
▸ TGFBR1 P36897 2/20 0.35
▸ TRPV1 Q8NER1 1/20 0.35
▸ CYP2E1 P05181 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ NFKB1 P19838 2/20 0.35
▸ NFKB2 Q00653 2/20 0.35
▸ RELA Q04206 2/20 0.35
▸ RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22583027 1.00 CYP2A6 (0.41) CYP2A6PDE10AMETAP2NOS3NOS1
SCHEMBL12781905 0.75 ATP4A (0.41) PDE10ACYP19A1NPC1KMT2AMAPT
SCHEMBL26627413 0.74 HTR2B (0.51) TGFBR1PIM1
SCHEMBL30189517 0.72 CYP2A6 (0.50) CYP2A6METAP2NOS3NOS1NOS2
SCHEMBL13801128 0.72 METAP2 (0.46) CYP2A6METAP2NOS3NOS1NOS2
SCHEMBL1924800 0.71 AXL (0.37) CYP19A1KMT2A
SCHEMBL196235 0.71 CYP2A6 (0.61) CYP2A6METAP2NOS3NOS1NOS2
SCHEMBL31252534 0.71 CYP2A6 (0.61) CYP2A6METAP2NOS3NOS1NOS2
SCHEMBL29924154 0.71 CYP2A6 (0.61) CYP2A6METAP2NOS3NOS1NOS2
SCHEMBL15825002 0.70 PDE10A (0.64) PDE10ACYP19A1NPC1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 — — EP disclosed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 — — CN disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 — — WO disclosed
EP-3959207-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2022-03-02 — — EP disclosed
Send feedback